Charles River Laboratories International Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Charles River Laboratories (CRL) stock underperformed competitors on Wednesday, sliding 2.34% to $234.80 amid a broader market decline. The S&P 500 and Dow Jones fell 1.52% and 2.19%, respectively. CRL closed 3.27% below its 52-week high of $242.73. Trading volume reached 1.1 million shares, exceeding the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. (CRL) slid 2.34% to $234.80 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.52% to 7,316.15 and Dow Jones Industrial Average falling 2.19% to 51,594.14.
Charles River Laboratories International Inc. closed 3.27% short of its 52-week high of $242.73, which the company achieved on July 28th.
The stock underperformed when compared to some of its competitors Wednesday, as Labcorp Holdings Inc. (LH) fell 2.25% to $307.15, Alnylam Pharmaceuticals Inc. (ALNY) fell 0.62% to $286.62, and Bio-Techne Corp. (TECH) fell 0.06% to $72.03.
Trading volume (1.1 M) eclipsed its 50-day average volume of 897,788.
Data source: Dow Jones Market Data, FactSet. Data compiled July 29, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-29-26 1716ET